The global Animal Triclabendazole market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Parasitic zoonoses have a dual impact by afflicting humans as well as animals, the latter causing substantial economic loss in livestock farming. Fascioliasis is a widely distributed zoonotic infection reported from almost half of all countries around the world, and it is caused by liver flukes of the genus Fasciola spp. Triclabendazole which has been proven to kill all three stages of liver fluke in sheep and cattle.
From 2010 to 2020, the global (excluding China) animal health market sales rose from 20.1 billion US dollars to 33.8 billion US dollars, an increase of 68.16%.
The CAGR is 5.33%.
According to relevant statistics from the China Veterinary Medicine Association and the International Animal Husbandry Network, as of the end of 2020, there were 1,633 veterinary drug manufacturers nationwide, of which over 95% had annual sales of less than 200 million yuan, and the sales of the top ten companies accounted for about 22%, far lower than the foreign veterinary drug market. Further, from the perspective of the market segment structure, due to the impact of differences in R&D and production barriers, the concentration of various products has differentiated, among which the concentration of biological products and veterinary APIs is relatively high. The average CR10 in 2016-2020 is respectively 55.51% and 43.83%; the concentration of veterinary chemical preparations and veterinary traditional Chinese medicines is relatively low, and the average CR10 from 2016 to 2020 is 23.55% and 19.82%, respectively.
The report includes an overview of the development of the Animal Triclabendazole industry chain, the market status of Sheep (100 mg/ml, 50 mg/ml), Cattle (100 mg/ml, 50 mg/ml), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Animal Triclabendazole.
Regionally, the report analyzes the Animal Triclabendazole markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Animal Triclabendazole market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Animal Triclabendazole market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Animal Triclabendazole industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., 100 mg/ml, 50 mg/ml).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Animal Triclabendazole market.
Regional Analysis: The report involves examining the Animal Triclabendazole market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Animal Triclabendazole market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Animal Triclabendazole:
Company Analysis: Report covers individual Animal Triclabendazole manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Animal Triclabendazole This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Sheep, Cattle).
Technology Analysis: Report covers specific technologies relevant to Animal Triclabendazole. It assesses the current state, advancements, and potential future developments in Animal Triclabendazole areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Animal Triclabendazole market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Animal Triclabendazole market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
100 mg/ml
50 mg/ml
120 mg/ml
麻豆原创 segment by Application
Sheep
Cattle
Pig
Others
Major players covered
Elanco
Zoetis
Boehringer Ingelheim
Bimeda
Chanelle Pharma
Virbac
Shijiazhuang Shimu Animal Pharmaceutical Co
Norbrook Laboratories Ltd
MSD Animal Health
Bayer Animal Health
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Animal Triclabendazole product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Animal Triclabendazole, with price, sales, revenue and global market share of Animal Triclabendazole from 2019 to 2024.
Chapter 3, the Animal Triclabendazole competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal Triclabendazole breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Animal Triclabendazole market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Animal Triclabendazole.
Chapter 14 and 15, to describe Animal Triclabendazole sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Animal Triclabendazole
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Animal Triclabendazole Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 100 mg/ml
1.3.3 50 mg/ml
1.3.4 120 mg/ml
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Animal Triclabendazole Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Sheep
1.4.3 Cattle
1.4.4 Pig
1.4.5 Others
1.5 Global Animal Triclabendazole 麻豆原创 Size & Forecast
1.5.1 Global Animal Triclabendazole Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Animal Triclabendazole Sales Quantity (2019-2030)
1.5.3 Global Animal Triclabendazole Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Elanco
2.1.1 Elanco Details
2.1.2 Elanco Major Business
2.1.3 Elanco Animal Triclabendazole Product and Services
2.1.4 Elanco Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Elanco Recent Developments/Updates
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Animal Triclabendazole Product and Services
2.2.4 Zoetis Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Zoetis Recent Developments/Updates
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Animal Triclabendazole Product and Services
2.3.4 Boehringer Ingelheim Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Bimeda
2.4.1 Bimeda Details
2.4.2 Bimeda Major Business
2.4.3 Bimeda Animal Triclabendazole Product and Services
2.4.4 Bimeda Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Bimeda Recent Developments/Updates
2.5 Chanelle Pharma
2.5.1 Chanelle Pharma Details
2.5.2 Chanelle Pharma Major Business
2.5.3 Chanelle Pharma Animal Triclabendazole Product and Services
2.5.4 Chanelle Pharma Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Chanelle Pharma Recent Developments/Updates
2.6 Virbac
2.6.1 Virbac Details
2.6.2 Virbac Major Business
2.6.3 Virbac Animal Triclabendazole Product and Services
2.6.4 Virbac Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Virbac Recent Developments/Updates
2.7 Shijiazhuang Shimu Animal Pharmaceutical Co
2.7.1 Shijiazhuang Shimu Animal Pharmaceutical Co Details
2.7.2 Shijiazhuang Shimu Animal Pharmaceutical Co Major Business
2.7.3 Shijiazhuang Shimu Animal Pharmaceutical Co Animal Triclabendazole Product and Services
2.7.4 Shijiazhuang Shimu Animal Pharmaceutical Co Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Shijiazhuang Shimu Animal Pharmaceutical Co Recent Developments/Updates
2.8 Norbrook Laboratories Ltd
2.8.1 Norbrook Laboratories Ltd Details
2.8.2 Norbrook Laboratories Ltd Major Business
2.8.3 Norbrook Laboratories Ltd Animal Triclabendazole Product and Services
2.8.4 Norbrook Laboratories Ltd Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Norbrook Laboratories Ltd Recent Developments/Updates
2.9 MSD Animal Health
2.9.1 MSD Animal Health Details
2.9.2 MSD Animal Health Major Business
2.9.3 MSD Animal Health Animal Triclabendazole Product and Services
2.9.4 MSD Animal Health Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 MSD Animal Health Recent Developments/Updates
2.10 Bayer Animal Health
2.10.1 Bayer Animal Health Details
2.10.2 Bayer Animal Health Major Business
2.10.3 Bayer Animal Health Animal Triclabendazole Product and Services
2.10.4 Bayer Animal Health Animal Triclabendazole Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Bayer Animal Health Recent Developments/Updates
3 Competitive Environment: Animal Triclabendazole by Manufacturer
3.1 Global Animal Triclabendazole Sales Quantity by Manufacturer (2019-2024)
3.2 Global Animal Triclabendazole Revenue by Manufacturer (2019-2024)
3.3 Global Animal Triclabendazole Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Animal Triclabendazole by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Animal Triclabendazole Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Animal Triclabendazole Manufacturer 麻豆原创 Share in 2023
3.5 Animal Triclabendazole 麻豆原创: Overall Company Footprint Analysis
3.5.1 Animal Triclabendazole 麻豆原创: Region Footprint
3.5.2 Animal Triclabendazole 麻豆原创: Company Product Type Footprint
3.5.3 Animal Triclabendazole 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Animal Triclabendazole 麻豆原创 Size by Region
4.1.1 Global Animal Triclabendazole Sales Quantity by Region (2019-2030)
4.1.2 Global Animal Triclabendazole Consumption Value by Region (2019-2030)
4.1.3 Global Animal Triclabendazole Average Price by Region (2019-2030)
4.2 North America Animal Triclabendazole Consumption Value (2019-2030)
4.3 Europe Animal Triclabendazole Consumption Value (2019-2030)
4.4 Asia-Pacific Animal Triclabendazole Consumption Value (2019-2030)
4.5 South America Animal Triclabendazole Consumption Value (2019-2030)
4.6 Middle East and Africa Animal Triclabendazole Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Animal Triclabendazole Sales Quantity by Type (2019-2030)
5.2 Global Animal Triclabendazole Consumption Value by Type (2019-2030)
5.3 Global Animal Triclabendazole Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Animal Triclabendazole Sales Quantity by Application (2019-2030)
6.2 Global Animal Triclabendazole Consumption Value by Application (2019-2030)
6.3 Global Animal Triclabendazole Average Price by Application (2019-2030)
7 North America
7.1 North America Animal Triclabendazole Sales Quantity by Type (2019-2030)
7.2 North America Animal Triclabendazole Sales Quantity by Application (2019-2030)
7.3 North America Animal Triclabendazole 麻豆原创 Size by Country
7.3.1 North America Animal Triclabendazole Sales Quantity by Country (2019-2030)
7.3.2 North America Animal Triclabendazole Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Animal Triclabendazole Sales Quantity by Type (2019-2030)
8.2 Europe Animal Triclabendazole Sales Quantity by Application (2019-2030)
8.3 Europe Animal Triclabendazole 麻豆原创 Size by Country
8.3.1 Europe Animal Triclabendazole Sales Quantity by Country (2019-2030)
8.3.2 Europe Animal Triclabendazole Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Animal Triclabendazole Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Animal Triclabendazole Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Animal Triclabendazole 麻豆原创 Size by Region
9.3.1 Asia-Pacific Animal Triclabendazole Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Animal Triclabendazole Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Animal Triclabendazole Sales Quantity by Type (2019-2030)
10.2 South America Animal Triclabendazole Sales Quantity by Application (2019-2030)
10.3 South America Animal Triclabendazole 麻豆原创 Size by Country
10.3.1 South America Animal Triclabendazole Sales Quantity by Country (2019-2030)
10.3.2 South America Animal Triclabendazole Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Animal Triclabendazole Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Animal Triclabendazole Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Animal Triclabendazole 麻豆原创 Size by Country
11.3.1 Middle East & Africa Animal Triclabendazole Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Animal Triclabendazole Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Animal Triclabendazole 麻豆原创 Drivers
12.2 Animal Triclabendazole 麻豆原创 Restraints
12.3 Animal Triclabendazole Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Animal Triclabendazole and Key Manufacturers
13.2 Manufacturing Costs Percentage of Animal Triclabendazole
13.3 Animal Triclabendazole Production Process
13.4 Animal Triclabendazole Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Animal Triclabendazole Typical Distributors
14.3 Animal Triclabendazole Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Elanco
Zoetis
Boehringer Ingelheim
Bimeda
Chanelle Pharma
Virbac
Shijiazhuang Shimu Animal Pharmaceutical Co
Norbrook Laboratories Ltd
MSD Animal Health
Bayer Animal Health
听
听
*If Applicable.
